AJP - Endocrinology and Metabolism, Vol 272, Issue 6 E1130-E1135, Copyright © 1997 by American Physiological Society

ARTICLES

Lipolytic responsiveness to epinephrine in nondiabetic and diabetic humans

G. D. Divertie, M. D. Jensen, P. E. Cryer and J. M. Miles
Department of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.

To determine whether the sensitivity of adipose tissue lipolysis to catecholamines is increased in poorly controlled insulin-dependent diabetes, the lipolytic response to epinephrine was measured in seven nondiabetic volunteers and seven poorly controlled diabetic subjects with use of [1-(14)C]palmitate as a tracer. Subjects received sequential 1-h infusions of epinephrine, which produced epinephrine concentrations of approximately 1,000, approximately 1,750, approximately 3,500, and approximately 6,000 pmol/l. A pancreatic clamp was used to maintain constant plasma hormone levels. Concentration-response curves were constructed for each subject from the integrated lipolytic response during each epinephrine infusion. There was no difference in maximal lipolytic response (117 +/- 19 vs. 152 +/- 11 mumol.kg-1.h-1) or in maximally effective (3,171 +/- 267 vs. 3,357 +/- 349 pmol/l) or half-maximally effective (1,081 +/- 109 vs. 1,015 +/- 120 pmol/l) epinephrine concentrations between nondiabetic and diabetic subjects, respectively (all P = NS). In control subjects, maximum beta-hydroxybutyrate concentrations were achieved at lower epinephrine concentrations than those required for a maximum lipolytic effect. Thus, under pancreatic clamp conditions, the lipolytic response to epinephrine in nondiabetic and diabetic subjects was similar.

This article has been cited by other articles:

				P. E. Cryer Mechanisms of Hypoglycemia-Associated Autonomic Failure and Its Component Syndromes in Diabetes Diabetes, December 1, 2005; 54(12): 3592 - 3601. [Abstract] [Full Text] [PDF]

				N. Hiscock, C. P. Fischer, M. Sacchetti, G. van Hall, M. A. Febbraio, and B. K. Pedersen Recombinant human interleukin-6 infusion during low-intensity exercise does not enhance whole body lipolysis or fat oxidation in humans Am J Physiol Endocrinol Metab, July 1, 2005; 289(1): E2 - E7. [Abstract] [Full Text] [PDF]

				J. F. Horowitz and S. Klein Whole body and abdominal lipolytic sensitivity to epinephrine is suppressed in upper body obese women Am J Physiol Endocrinol Metab, June 1, 2000; 278(6): E1144 - E1152. [Abstract] [Full Text] [PDF]

				C. Le Fur, M. Romon, P. Lebel, P. Devos, A. Lancry, L. Guedon-Moreau, J.-C. Fruchart, and J. Dallongeville Influence of mental stress and circadian cycle on postprandial lipemia Am. J. Clinical Nutrition, August 1, 1999; 70(2): 213 - 220. [Abstract] [Full Text] [PDF]

				J. F. Horowitz, R. J. Braudy, W. H. Martin III, and S. Klein Endurance exercise training does not alter lipolytic or adipose tissue blood flow sensitivity to epinephrine Am J Physiol Endocrinol Metab, August 1, 1999; 277(2): E325 - E331. [Abstract] [Full Text] [PDF]